TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
5.11
+0.09 (1.79%)
At close: May 12, 2025, 4:00 PM
5.11
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
TriSalus Life Sciences Market Cap
TriSalus Life Sciences has a market cap or net worth of $164.91 million as of May 12, 2025. Its market cap has decreased by -39.81% in one year.
Market Cap
164.91M
Enterprise Value
180.02M
1-Year Change
-39.81%
Ranking
Category
Stock Price
$5.11
Market Cap Chart
Since February 8, 2021, TriSalus Life Sciences's market cap has decreased from $328.75M to $164.91M, a decrease of -49.84%. That is a compound annual growth rate of -14.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 162.01M | 6.05% |
| Dec 31, 2024 | 152.77M | -31.30% |
| Dec 29, 2023 | 222.38M | -29.05% |
| Dec 30, 2022 | 313.44M | 1.52% |
| Dec 31, 2021 | 308.75M | -6.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |